Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19
Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19
Active, not recruiting · NCT04547257 · Registry updated 2026-04-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not applicable | 2026-04-20 | NCT04547257 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ExThera Medical Corporation | 3 |
| Vivantes Clinic Neukölln | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Clinico San Carlos | Madrid | Spain | 103 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 200 |
| Klinikum Aschaffenburg-Alzenau | Aschaffenburg | Germany | 2 |
| Universitätsklinikum Essen | Essen | Germany | 39 |
| Vivantes Klinikum Neukölln | Berlin | Germany | 8 |